← Leaderboards
Pau Castel
University Of California, San Francisco
$2,167,505
Attributed
$2,400,567
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,400,567 · 4
By mechanism
R01$1,087,640 · 1
R00$632,714 · 1
R21$466,125 · 1
K99$214,088 · 1
Top collaborators
- Mark Reid Philips1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Brian L Black$22,286,259
- Sanjeev A. Datar$6,321,149
- Vishal Nigam$3,861,345
- Elizabeth M Ozer$2,777,748
- Emin Maltepe$6,606,015
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesExperimental StudyTumorPathway InteractionsMalignant NeoplasmsBiochemicalMolecularSignal TransductionCellsInsightComplexMolecular ConformationLung AdenocarcinomaMalignant Neoplasm Of LungMediatingMutationCancer BiologyGuanosine DiphosphateIn VitroMemberCell ProliferationInnovationBindingFuture
Grant awards (8)
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission$543,820
R01 · FY2025 · CA · contact PI
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission$543,820
R01 · FY2024 · CA · contact PI
Energetic metabolism in RASopathies as a novel therapeutic target$466,125
R21 · FY2024 · HD · contact PI
The role of Sin1 in Kras-driven cancer$249,000
R00 · FY2023 · CA · contact PI
The role of Sin1 in Kras-driven cancer$134,714
R00 · FY2022 · CA · contact PI
The role of Sin1 in Kras-driven cancer$249,000
R00 · FY2021 · CA · contact PI
The role of Sin1 in Kras-driven cancer$107,044
K99 · FY2021 · CA · contact PI
The role of Sin1 in Kras-driven cancer$107,044
K99 · FY2020 · CA · contact PI